Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes | NEJM
Obesity and type 2 diabetes are prevalent in patients with heart failure with preserved ejection fraction and are characterized by a high symptom burden. No approved therapies specifically target o…